Preclinical Vaccine Development THAA01
Type:
Oral abstract session Back
Venue: Session Room 6
Interpretation: None
Time: 10:45 - 12:15
Code: THAA01
Co-Chairs: Pontiano Kaleebu, Uganda
Kelly MacDonald, Canada

    Presentations in this session:
10:45
THAA0101
Abstract
Powerpoint (3.05 MB)
Enhanced HIV/SIV specific cellular immunity in macaques following a novel peptide immunotherapy (OPAL)
Presented by Stephen Kent, Australia
S. Kent, S. Chea, R. De Rose, C.J. Batten
University of Melbourne, Microbiology and Immunology, Parkville, Australia

11:00
THAA0102
Abstract
Non-infectious papilloma virus - like particles (VLPs) inhibit HIV replication: implications for immune control of HIV replication by IL-27
Presented by J.Mohamad Fakruddin, United States
J.M. Fakruddin1, R. Lempicki2, J. Yang2, J. Adelsberger3, A. Pineres4, L. Pinto4, H.C. Lane5, T. Imamichi1
1Laboratory of Human Retrovirology, SAIC/NCI-Frederick, Frederick, United States, 2Laboratory of Immunopathogenesis and Bioinformatics, SAIC/NCI-Frederick, Frederick, United States, 3AIDS Monitoring Laboratory, SAIC/NCI-Frederick, Frederick, United States, 4HPV Monitoring Laboratory, SAIC/NCI-Frederick, Frederick, United States, 5Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, United States

11:15
THAA0103
Abstract
Powerpoint (4.59 MB)
Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV
Presented by Kenji Okuda
K.-Q. Xin1, K. Someya2, A. Yoshida1, M. Honda2, K. Okuda1
1Yokohama City University, Molecular Biodefense Research, Yokohama, Japan, 2National Institute of Infectious Diseases, AIDS Research Center, Tokyo, Japan

11:30
THAA0104
Abstract
Comparative evaluation of CD70, LIGHT and 4-1BBL, as costimulators of human anti-viral memory CD8 T cells
Presented by Chao Wang, Canada
C. Wang, T. Wen, T. Watts
University of Toronto, Department of Immunology, Toronto, Canada

11:45
THAA0105
Abstract
Chimeric CD40L/SHIV virus-like particles enhanced dendritic cells activation and boosted immune responses against HIV
Presented by Qizhi Yao, United States
R. Zhang, M. Li, C. Chen, Q. Yao
Baylor College of Medicine, Houston, United States





Audio files:
  1. English audio file (mp3 format, 23.6 MB)

Rapporteur reports

Science Track A: Biology and Pathogenesis of HIV report by Dr. Rafick-Pierre Sèkaly

This session incudeed several presentations that focused on different approaches that can trigger or enhace potent cellular and humoral respones . These approaches included the development of novel delivery systems such as vectors or viral particles , cytokines and also the inclusion in vaccines of molecules that can enhance immune responses . [

Dr S Kent presented a novel approach or OPAL which consists in loading peripheral blood mononuclear cells or whole blood with SIV peptides and reinfusing these cells into infected macaques to determine whether such loaded cells can trigger immune responses to the peptides . He was able to demonstrate that such loaded cells were indeed able to induce the production of cytokines after in vivo immunisation with laoded cells . This approach is safe and can be used without any prior knowledge of HLA polymorphism .  It remains to be seen whether such immune responses are protetive and whether they can allow the control of viral load .

Dr Fakruddin pesented a very interstung set of exoperiments showing that the HPV VLPs can induce the production of IL-27 by monocytes and dendritic cells leading to the control of viral replication in CD4 cells . Il-27 in a recombinant form was able to mimick such an effect and of note IL-27 production inhibited the replciation of both X4 and R5 strains .

[Major themes in the discussion, including comments from the audience, quotes and recommendations]




Science Track A: Biology and Pathogenesis of HIV report by Dr. Rafick-Pierre Sèkaly

This session included several presentations that focused on different approaches that can trigger or enhance potent cellular and humoral responses . These approaches included the development of novel delivery systems such as vectors or viral particles , cytokines and also the inclusion in vaccines of molecules that can enhance immune responses . [

Dr S Kent presented a novel approach or OPAL which consists in loading peripheral blood mononuclear cells or whole blood with SIV peptides and reinfusing these cells into infected macaques to determine whether such loaded cells can trigger immune responses to the peptides . He was able to demonstrate that such loaded cells were indeed able to induce the production of cytokines after in vivo immunization with loaded cells . This approach is safe and can be used without any prior knowledge of HLA polymorphism .  It remains to be seen whether such immune responses are protective and whether they can allow the control of viral load .

Dr Fakruddin presented a very interesting set of experiments showing that the HPV VLPs can induce the production of IL-27 by monocytes and dendritic cells leading to the control of viral replication in CD4 cells . Il-27 in a recombinant form was able to mimic such an effect and of note IL-27 production inhibited the replication of both X4 and R5 strains .

Dr Xin generated recombinant adenoviruses between Ad5 and which included the fiber of Ad35 . These chimeric viruses were much more efficient in infecting Dendritic cells ( DCs) . In vivo they triggered in mice more potent immune responses than vaccinia vectors or Ad5 encompassing the same immunogen . They were more immunogenic in primates . Finally they were capable of inducing a more efficient control of viral replciation in macaques that had been immunized during HAART treatment and in which treatment was interrupted . 

Dr Wang explored the capacity of different ligands  of  TNF-R family members to induce the proliferation and effector and functional differentiation of CD8 T cells . She used CD70 ( CD27)  LIGHT , 4-1BBL  and showed that CD70 and 4-1BBL alone and in combination were very potent in inducing effector function of CD8 memory T cells . This offers very exciting perspectives for the development of novel adjuvants of T cells responses.

Dr Zhang presented also as very original system to induce strong cellular and humoral responses . This system relied on the expression by SHIV VLPs of CD40L ; incorporation of CD40L in these VLPs led to a much more efficient maturation of DCs as evidenced by the expression of several cell surface markers associated with mature DCs , the capacity to induce strong allogeneic responses and the increased production of cytokines such as IL-12 . More importantly these VLPs which included CD40L were very potent in inducing strong cellular and humoral responses specific for the SHIV envelope.

Altogether the talks in this session highlighted novel pathways which can boost immune responses a much needed tool in the quest for an HIV vaccine .

 




    Add this session to your itinerary and back

    Back to the Programme-at-a-Glance



    The organizers reserve the right to amend the programme.

Copyright Notice © IAS Disclaimer